Literature DB >> 21745676

Refining the estimation of illicit drug consumptions from wastewater analysis: co-analysis of prescription pharmaceuticals and uncertainty assessment.

Foon Yin Lai1, Christoph Ort, Coral Gartner, Steve Carter, Jeremy Prichard, Paul Kirkbride, Raimondo Bruno, Wayne Hall, Geoff Eaglesham, Jochen F Mueller.   

Abstract

Wastewater analysis is a promising monitoring tool to estimate illicit drug consumption at the community level. The advantage of this technique over traditional surveys and other surveillance methods has been emphasized in recent studies. However, there are methodological challenges that can affect reliability. The objectives of this study were to systematically reduce and assess uncertainties associated with sampling (through a stringent optimization of the sampling method) and the back calculation of per capita drug consumption (through a refined estimation of the number of people actively contributing to the wastewater in a given period). We applied continuous flow-proportional sampling to ensure the collection of representative raw wastewater samples. Residues of illicit drugs, opioids, prescription pharmaceuticals and one artificial sweetener were analyzed by liquid chromatography coupled with tandem mass spectrometry. A parameter estimating the number of people actively contributing to wastewater over a given period was calculated from the measured loads of prescription pharmaceuticals, their annual consumption and relative excretion data. For the calculation of substance loads in sewage, uncertainties were propagated considering five individual components: sampling, chemical analysis, flow measurements, excretion rates and the number of people contributing to the wastewater. The daily consumption per 1000 inhabitants was estimated to be almost 1000 mg for cannabis and several hundred mg for cocaine, methamphetamine and ecstasy. With the best sampling practice and current chemical analysis, we calculated the remaining uncertainty to be in the range of 20-30% (relative standard deviation, RSD) for the estimation of consumed drug masses in the catchment; RSDs for the per capita consumption were lower (14-24%), as one of the biggest uncertainty components (i.e. error in flow measurements) cancels out in the proposed method for the estimation of the number of people contributing to the daily wastewater volume. In this study, we provide methodological improvements that substantially enhance the reliability of the estimation method--a prerequisite for the application of this technique to meaningfully assess changes in drug consumption and the success of drug intervention strategies in future studies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745676     DOI: 10.1016/j.watres.2011.05.042

Source DB:  PubMed          Journal:  Water Res        ISSN: 0043-1354            Impact factor:   11.236


  22 in total

1.  Do concentrations of pharmaceuticals in sewage reflect prescription figures?

Authors:  Alexander L N van Nuijs; Adrian Covaci; Herman Beyers; Lieven Bervoets; Ronny Blust; Gert Verpooten; Hugo Neels; Philippe G Jorens
Journal:  Environ Sci Pollut Res Int       Date:  2015-01-13       Impact factor: 4.223

2.  Normalized diurnal and between-day trends in illicit and legal drug loads that account for changes in population.

Authors:  Alex J Brewer; Christoph Ort; Caleb J Banta-Green; Jean-Daniel Berset; Jennifer A Field
Journal:  Environ Sci Technol       Date:  2012-07-17       Impact factor: 9.028

3.  Occurrence, removal and environmental risk of markers of five drugs of abuse in urban wastewater systems in South Australia.

Authors:  Meena K Yadav; Michael D Short; Cobus Gerber; Ben van den Akker; Rupak Aryal; Christopher P Saint
Journal:  Environ Sci Pollut Res Int       Date:  2018-06-09       Impact factor: 4.223

4.  Stability of cocaine and its metabolites in municipal wastewater--the case for using metabolite consolidation to monitor cocaine utilization.

Authors:  Kevin J Bisceglia; Katrice A Lippa
Journal:  Environ Sci Pollut Res Int       Date:  2013-12-12       Impact factor: 4.223

Review 5.  Potential ecological footprints of active pharmaceutical ingredients: an examination of risk factors in low-, middle- and high-income countries.

Authors:  Rai S Kookana; Mike Williams; Alistair B A Boxall; D G Joakim Larsson; Sally Gaw; Kyungho Choi; Hiroshi Yamamoto; Shashidhar Thatikonda; Yong-Guan Zhu; Pedro Carriquiriborde
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-11-19       Impact factor: 6.237

6.  Using wastewater-based analysis to monitor the effects of legalized retail sales on cannabis consumption in Washington State, USA.

Authors:  Daniel A Burgard; Jason Williams; Danielle Westerman; Rosie Rushing; Riley Carpenter; Addison LaRock; Jane Sadetsky; Jackson Clarke; Heather Fryhle; Melissa Pellman; Caleb J Banta-Green
Journal:  Addiction       Date:  2019-06-18       Impact factor: 6.526

7.  Wastewater testing compared with random urinalyses for the surveillance of illicit drug use in prisons.

Authors:  Alex J Brewer; Caleb J Banta-Green; Christoph Ort; Alix E Robel; Jennifer Field
Journal:  Drug Alcohol Rev       Date:  2014-08-07

8.  Prevalence of illicit and prescribed neuropsychiatric drugs in three communities in Kentucky using wastewater-based epidemiology and Monte Carlo simulation for the estimation of associated uncertainties.

Authors:  Tara L Croft; Rhiannon A Huffines; Manoj Pathak; Bikram Subedi
Journal:  J Hazard Mater       Date:  2019-09-24       Impact factor: 10.588

9.  Isotope pattern deconvolution as a successful alternative to calibration curve for application in wastewater-based epidemiology.

Authors:  Jorge Pitarch-Motellón; Lubertus Bijlsma; Juan Vicente Sancho Llopis; Antoni F Roig-Navarro
Journal:  Anal Bioanal Chem       Date:  2021-03-17       Impact factor: 4.142

10.  Mining chemical information in Swedish wastewaters for simultaneous assessment of population consumption, treatment efficiency and environmental discharge of illicit drugs.

Authors:  Inga Haalck; Paul Löffler; Christine Baduel; Karin Wiberg; Lutz Ahrens; Foon Yin Lai
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.